Patents by Inventor Peter T. Daniel

Peter T. Daniel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substances for the therapy of diseases caused by highly proliferating cells
    Publication number: 20040116448
    Abstract: The invention relates to medicaments and compounds for the treatment of diseases caused by highly proliferating cells, such as tumor cells, especially blasts of children suffering from acute leukemia. The invention also relates to the preparation of the corresponding medicaments and compounds.
    Type: Application
    Filed: January 29, 2004
    Publication date: June 17, 2004
    Inventors: Hans-Gunther Schmalz, Aram Prokop, Thomas P. Wieder, Peter T. Daniel
  • Monoclonal antibodies to the APO-1 antigen
    Patent number: 5891434
    Abstract: The APO-1 cellular membrane antigen, an about 50 kDa antigen associated with cellular apoptosis, and purified cDNA encoding same is described. The antigen is expressed by numerous normal and malignant cells, including activated and malignant lymphoid cells. Also disclosed are antibodies which bind the antigen, and which induce growth inhibition and apoptosis.
    Type: Grant
    Filed: March 23, 1995
    Date of Patent: April 6, 1999
    Assignee: Centocor, Inc.
    Inventors: Peter H. Krammer, Klaus-Michael Debatin, Bernhard C. Trauth, Iris Behrmann, Jens Dhein, Christiane Klas, Peter Moller, Werner Falk, Alexander Oehm, Peter T. Daniel